19
Views
19
CrossRef citations to date
0
Altmetric
Review

Photosensitising drugs - their potential in oncology

, &
Pages 1967-1979 | Published online: 23 Feb 2005
 

Abstract

Despite decades of targeted research, cancer remains a leading cause of death. Around one third of the population of Western Europe and North America will develop cancer in their lifetime and, virtually without exception, all of us will be affected by the disease, either directly as patients or by repercussions in family and friends. In certain specific cancers, advances in surgery, chemotherapy and radiotherapy have led to major achievements, but in many types of cancer there has been little or no improvement in long-term survival. In yet other cases, whilst there may be good initial responses to drug therapy, drug resistance develops and additional agents are required to induce further remission in these patients. There is therefore a clear need for new anticancer agents and novel therapies. It is in this context that photosensitising drugs may play a significant part.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.